AMETEK(AME) - 2025 Q3 - Quarterly Report
AMETEKAMETEK(US:AME)2025-10-30 18:29

Financial Performance - Net sales for Q3 2025 reached a record $1,892.6 million, an increase of $184.0 million or 10.8% compared to Q3 2024[109] - Consolidated operating income for Q3 2025 was $488.4 million, an increase of $42.5 million or 9.5% compared to Q3 2024[115] - Net income for Q3 2025 was $371.4 million, an increase of $31.2 million or 9.2% compared to Q3 2024[117] - Diluted earnings per share for Q3 2025 were $1.60, an increase of $0.13 or 8.8% compared to Q3 2024[118] - For the first nine months of 2025, net sales were $5,402.7 million, an increase of $223.1 million or 4.3% compared to the same period in 2024[123] - Segment operating income for the first nine months of 2025 was $1,487.4 million, an increase of $100.3 million or 7.2% compared to the same period in 2024[127] Sales and Orders - International sales for Q3 2025 were $906.1 million, accounting for 47.9% of net sales, up $92.6 million or 11.4% from Q3 2024[110] - Orders for Q3 2025 totaled a record $1,967.8 million, an increase of $224.4 million or 12.9% compared to Q3 2024[111] - The backlog of unfilled orders at September 30, 2025 was a record $3,546.3 million, up $143.1 million or 4.2% from December 31, 2024[111] - Total international sales for the first nine months of 2025 were $2,559.0 million, accounting for 47.4% of net sales, up $132.1 million or 5.4% from the same period in 2024[124] - EMG's net sales for the first nine months of 2025 reached $1,853.1 million, a 6.8% increase from $1,734.6 million in the same period of 2024, driven by a 6% organic sales increase and a 1% favorable foreign currency translation effect[136] Cash Flow and Investments - Cash provided by operating activities decreased by 4.8% to $1,217.5 million for the first nine months of 2025, compared to $1,278.8 million in the same period of 2024, primarily due to higher working capital investments[138] - Free cash flow for the first nine months of 2025 was $1,144.2 million, down from $1,203.5 million in the same period of 2024, while EBITDA increased to $1,696.0 million from $1,590.5 million[139] - Cash used in investing activities surged to $1,005.8 million in the first nine months of 2025, primarily due to the acquisition of Kern Microtechnik and FARO Technologies, compared to $69.5 million in the same period of 2024[140] Debt and Dividends - Total debt, net, increased to $2,464.2 million as of September 30, 2025, from $2,079.7 million at the end of 2024, with a debt-to-capital ratio of 19.0%[141] - Cash dividends paid increased to $214.4 million for the first nine months of 2025, up from $194.1 million in the same period of 2024, reflecting an 11% increase in the quarterly cash dividend[143] Compliance and Risks - The company is in compliance with all covenants for its debt agreements and believes it has sufficient cash-generating capabilities to meet its operating needs[145] - Forward-looking statements indicate potential risks including supply chain disruptions, competition, and the ability to successfully integrate future acquisitions[147]